BPC-157 Treats Esophagitis Caused by Pyloric Sphincter Dysfunction in Rats
BPC-157 healed prolonged esophagitis resulting from pyloric sphincter dysfunction in rats, improving both esophageal mucosal healing and sphincter function — addressing the root cause of this reflux model.
Quick Facts
What This Study Found
BPC-157 healed prolonged esophagitis caused by primary pyloric sphincter dysfunction in rats, improving mucosal integrity and sphincter function — demonstrating efficacy in a reflux model where the underlying cause is sphincter failure.
Key Numbers
How They Did This
animal-study study on bpc-157, gut-healing.
Why This Research Matters
Relevant for bpc-157, gut-healing.
The Bigger Picture
Advances peptide research.
What This Study Doesn't Tell Us
See abstract.
Questions This Raises
- ?Further research needed.
- ?Clinical translation to evaluate.
Trust & Context
- Key Stat:
- Key finding BPC-157 healed prolonged esophagitis caused by primary pyloric sphincter dysfunction in rats, improving mucosal integrity and sphincter function — dem
- Evidence Grade:
- moderate evidence.
- Study Age:
- Published in 2007.
- Original Title:
- Prolonged esophagitis after primary dysfunction of the pyloric sphincter in the rat and therapeutic potential of the gastric pentadecapeptide BPC 157.
- Published In:
- Journal of pharmacological sciences, 104(1), 7-18 (2007)
- Authors:
- Dobric, Ivan(6), Drvis, Petar(3), Petrovic, Igor(3), Shejbal, Drazen, Brcic, Luka, Blagaic, Alenka Boban, Batelja, Lovorka, Sever, Marko, Kokic, Neven, Tonkic, Ante, Zoricic, Ivan, Mise, Sandro, Staresinic, Mario, Radic, Bozo, Jakir, Ana, Babel, Jaksa, Ilic, Spomenko, Vuksic, Tihomir, Jelic, Ivan, Anic, Tomislav, Seiwerth, Sven, Sikiric, Predrag
- Database ID:
- RPEP-01220
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
What was studied?
BPC-157 Treats Esophagitis Caused by Pyloric Sphincter Dysfunction in Rats
What was found?
BPC-157 healed prolonged esophagitis resulting from pyloric sphincter dysfunction in rats, improving both esophageal mucosal healing and sphincter function — addressing the root cause of this reflux model.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-01220APA
Dobric, Ivan; Drvis, Petar; Petrovic, Igor; Shejbal, Drazen; Brcic, Luka; Blagaic, Alenka Boban; Batelja, Lovorka; Sever, Marko; Kokic, Neven; Tonkic, Ante; Zoricic, Ivan; Mise, Sandro; Staresinic, Mario; Radic, Bozo; Jakir, Ana; Babel, Jaksa; Ilic, Spomenko; Vuksic, Tihomir; Jelic, Ivan; Anic, Tomislav; Seiwerth, Sven; Sikiric, Predrag. (2007). Prolonged esophagitis after primary dysfunction of the pyloric sphincter in the rat and therapeutic potential of the gastric pentadecapeptide BPC 157.. Journal of pharmacological sciences, 104(1), 7-18.
MLA
Dobric, Ivan, et al. "Prolonged esophagitis after primary dysfunction of the pyloric sphincter in the rat and therapeutic potential of the gastric pentadecapeptide BPC 157.." Journal of pharmacological sciences, 2007.
RethinkPeptides
RethinkPeptides Research Database. "Prolonged esophagitis after primary dysfunction of the pylor..." RPEP-01220. Retrieved from https://rethinkpeptides.com/research/dobric-2007-prolonged-esophagitis-after-primary
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.